Developer docs
API playgroundTry for free, no card

Search company profiles

Advanced Life Sciences Holdings

Full company profile

uuid003vo1o

Namestring
Advanced Life Sciences Holdings
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company that has historically been positioned around the discovery, development, and commercialization of drugs. The entity traces back to 1998 and previously traded on NASDAQ under the ticker ADLS before being delisted; it is now headquartered in Woodridge, Illinois, with a reported headcount of 1–10 employees. The current corporate website at advancedlifesciences.com is a placeholder "Launching Soon" page with a generic contact form and email sign-up, indicating the business is in a pre-commercial build-out phase rather than an active operating state.

There is no disclosed information on products, pipeline assets, indications, modalities, technology platforms, partnerships, management, funding, or revenue in the available data. As a result, the company description is necessarily limited to its stated category (biopharmaceutical drug development and commercialization), its prior public-market status, its small current scale, and the pre-launch posture conveyed by its web presence. No pricing, go-to-market, customer segment, or revenue model detail can be evidenced from the source material.

Short descriptiontext

Advanced Life Sciences Holdings is a small biopharmaceutical company focused on drug discovery, development, and commercialization. Founded in 1998 and based in Woodridge, Illinois, it operates a pre-launch website under its prior NASDAQ:ADLS brand with no disclosed products or revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWoodridge, United States
HQ citystring
Woodridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biopharmaceutical development, drug discovery, drug commercialization, therapeutic research, pharmaceutical holdings
Industry1 code
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Biopharmaceutical Drug Development
Social media profiles1 record
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Advanced Life Sciences Holdings, Inc. is described as a biopharmaceutical company focused on the discovery, development, and commercialization of drugs. The company's current public-facing website is a 'Launching Soon' placeholder page with no specific products, pipeline assets, or services listed.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No product or service information is available. The company website displays only a 'Launching Soon' placeholder page with no product descriptions, offerings, or portfolio details.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Biopharmaceutical company developing antibiotics for serious infections. Directly comparable as a small-cap anti-infective drug developer with similar therapeutic area and commercialization-stage ambitions to Advanced Life Sciences.

TypeOthers
Description

Former biopharmaceutical company that developed and commercialized antibiotics, now serves as a cautionary historical peer for small-cap anti-infective drug developers like Advanced Life Sciences given the well-documented capital and commercialization challenges in this therapeutic area.

TypeDirect peer
Description

Clinical-stage biopharmaceutical company developing anti-infective therapeutics. Comparable as a small-cap drug discovery and development company in the anti-infective space with similar commercialization-stage positioning.

TypeDirect peer
Description

Clinical-stage biopharmaceutical company developing differentiated antibacterial products. Comparable anti-infective focus and small-cap biopharma profile aligned with Advanced Life Sciences' historical therapeutic area.

TypeBroad incumbent
Description

Clinical-stage biopharmaceutical company developing microbiome therapeutics. Comparable as a U.S.-based, small/mid-cap biopharma with a discovery, development and commercialization mandate in therapeutic drug development.

6Nabriva Therapeutics
TypeDirect peer
Description

Biopharmaceutical company focused on developing and commercializing novel anti-infective agents. Highly comparable to Advanced Life Sciences given overlapping anti-infective/antibiotic therapeutic focus and similar small-cap, development-stage profile.

TypeDirect peer
Description

Private biopharmaceutical company developing novel anti-infective therapies to address drug-resistant bacterial infections. Comparable as a small-cap biopharma focused on anti-infective drug discovery and development.

TypeDirect peer
Description

Clinical-stage biopharmaceutical company developing anti-infective drugs. Comparable as a small-cap, development-stage drug company focused on therapeutic commercialization, similar in profile to Advanced Life Sciences' historical anti-infective orientation.

TypeDirect peer
Description

Small-cap U.S. biopharmaceutical company developing and commercializing therapeutic drugs, including anti-infectives. Directly comparable to Advanced Life Sciences' stated focus on drug discovery, development and commercialization at a similar small-cap scale.

TypeDirect peer
Description

Biopharmaceutical company focused on developing tetracycline-derived antibiotics. Comparable as a small-cap anti-infective drug developer with similar discovery-to-commercialization trajectory to Advanced Life Sciences.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Advanced Life Sciences Holdings

Biopharmaceutical Drug Developmentadvancedlifesciences.com

Advanced Life Sciences Holdings is a small biopharmaceutical company focused on drug discovery, development, and commercialization. Founded in 1998 and based in Woodridge, Illinois, it operates a pre-launch website under its prior NASDAQ:ADLS brand with no disclosed products or revenue.

What Advanced Life Sciences Holdings does

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company that has historically been positioned around the discovery, development, and commercialization of drugs. The entity traces back to 1998 and previously traded on NASDAQ under the ticker ADLS before being delisted; it is now headquartered in Woodridge, Illinois, with a reported headcount of 1–10 employees. The current corporate website at advancedlifesciences.com is a placeholder "Launching Soon" page with a generic contact form and email sign-up, indicating the business is in a pre-commercial build-out phase rather than an active operating state.

There is no disclosed information on products, pipeline assets, indications, modalities, technology platforms, partnerships, management, funding, or revenue in the available data. As a result, the company description is necessarily limited to its stated category (biopharmaceutical drug development and commercialization), its prior public-market status, its small current scale, and the pre-launch posture conveyed by its web presence. No pricing, go-to-market, customer segment, or revenue model detail can be evidenced from the source material.

Advanced Life Sciences Holdings firmographics

Firmographics
Name
Advanced Life Sciences Holdings
Website
https://advancedlifesciences.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
Advanced Life Sciences Holdings is a small biopharmaceutical company focused on drug discovery, development, and commercialization. Founded in 1998 and based in Woodridge, Illinois, it operates a pre-launch website under its prior NASDAQ:ADLS brand with no disclosed products or revenue.
Ownership category
akta.pro rank

Advanced Life Sciences Holdings industry classification

Industry
Product category
Biopharmaceutical Drug Development
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Biopharmaceutical development
  • Drug discovery
  • Drug commercialization
  • Therapeutic research
  • Pharmaceutical holdings

Where Advanced Life Sciences Holdings is headquartered

Location

Headquarters

HQ city
Woodridge
HQ country
United States
HQ region
North America

Markets served

Advanced Life Sciences Holdings business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations

Advanced Life Sciences Holdings product offering

Product offering

Core offering

Advanced Life Sciences Holdings, Inc. is described as a biopharmaceutical company focused on the discovery, development, and commercialization of drugs. The company's current public-facing website is a 'Launching Soon' placeholder page with no specific products, pipeline assets, or services listed.

Product overview

No product or service information is available. The company website displays only a 'Launching Soon' placeholder page with no product descriptions, offerings, or portfolio details.

Differentiator

Problem solved

Functional benefit

Companies that use Advanced Life Sciences Holdings

Customer profile

Ideal customer profiles1 record

Advanced Life Sciences Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Advanced Life Sciences Holdings partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Advanced Life Sciences Holdings competitors and assessment

Company assessment

Direct peers

  • Melinta Therapeutics: Biopharmaceutical company developing antibiotics for serious infections. Directly comparable as a small-cap anti-infective drug developer with similar therapeutic area and commercialization-stage ambitions to Advanced Life Sciences.
  • Cidara Therapeutics: Clinical-stage biopharmaceutical company developing anti-infective therapeutics. Comparable as a small-cap drug discovery and development company in the anti-infective space with similar commercialization-stage positioning.
  • Entasis Therapeutics: Clinical-stage biopharmaceutical company developing differentiated antibacterial products. Comparable anti-infective focus and small-cap biopharma profile aligned with Advanced Life Sciences' historical therapeutic area.
  • Nabriva Therapeutics: Biopharmaceutical company focused on developing and commercializing novel anti-infective agents. Highly comparable to Advanced Life Sciences given overlapping anti-infective/antibiotic therapeutic focus and similar small-cap, development-stage profile.
  • VenatoRx Pharmaceuticals: Private biopharmaceutical company developing novel anti-infective therapies to address drug-resistant bacterial infections. Comparable as a small-cap biopharma focused on anti-infective drug discovery and development.
  • Iterum Therapeutics: Clinical-stage biopharmaceutical company developing anti-infective drugs. Comparable as a small-cap, development-stage drug company focused on therapeutic commercialization, similar in profile to Advanced Life Sciences' historical anti-infective orientation.
  • Paratek Pharmaceuticals: Small-cap U.S. biopharmaceutical company developing and commercializing therapeutic drugs, including anti-infectives. Directly comparable to Advanced Life Sciences' stated focus on drug discovery, development and commercialization at a similar small-cap scale.
  • Tetraphase Biosciences: Biopharmaceutical company focused on developing tetracycline-derived antibiotics. Comparable as a small-cap anti-infective drug developer with similar discovery-to-commercialization trajectory to Advanced Life Sciences.

Others

  • Achaogen: Former biopharmaceutical company that developed and commercialized antibiotics, now serves as a cautionary historical peer for small-cap anti-infective drug developers like Advanced Life Sciences given the well-documented capital and commercialization challenges in this therapeutic area.

Broad incumbents

  • Seres Therapeutics: Clinical-stage biopharmaceutical company developing microbiome therapeutics. Comparable as a U.S.-based, small/mid-cap biopharma with a discovery, development and commercialization mandate in therapeutic drug development.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights3 records

Customer concentration

Advanced Life Sciences Holdings social profiles

Digital presence

Advanced Life Sciences Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Advanced Life Sciences Holdings leadership team

Management profile

Number of profiles

Advanced Life Sciences Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Advanced Life Sciences Holdings M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Life Sciences Holdings

What does Advanced Life Sciences Holdings do?

Advanced Life Sciences Holdings, Inc. is described as a biopharmaceutical company focused on the discovery, development, and commercialization of drugs. The company's current public-facing website is a 'Launching Soon' placeholder page with no specific products, pipeline assets, or services listed.

When was Advanced Life Sciences Holdings founded?

Advanced Life Sciences Holdings was founded in 1998. It employs 1 to 10 people.

Where is Advanced Life Sciences Holdings based?

Advanced Life Sciences Holdings is headquartered in Woodridge, United States, in the North America region.

Who are Advanced Life Sciences Holdings's main competitors?

Direct peers on record are Melinta Therapeutics, Cidara Therapeutics, Entasis Therapeutics, Nabriva Therapeutics, VenatoRx Pharmaceuticals, Iterum Therapeutics, Paratek Pharmaceuticals and Tetraphase Biosciences. Achaogen is listed as an others. Seres Therapeutics is listed as a broad incumbent.

Does Advanced Life Sciences Holdings have an API?

No public API is recorded for Advanced Life Sciences Holdings.

What industry is Advanced Life Sciences Holdings in?

Advanced Life Sciences Holdings's product category is Biopharmaceutical Drug Development. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 541714 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals